ADA/EASD updated guidelines: glycemic control is only part of the management of type 2 diabetes

Clinical Question

What are the current recommendations from American and European professional societies for the treatment of type 2 diabetes?

Bottom line

The management of patients with type 2 diabetes continues to move away from glycemic goal chasing and toward a more holistic approach to patient care that also considers medications, weight management, attention to cardiovascular risk factors, and kidney protection. Metformin is recommended for most patients, though the new classes of medicines that affect the heart and kidneys should also be considered for many patients. Sulfonylureas, thiazolidinediones, and insulin, all of which have little effect except to lower blood glucose levels, are distinctly de-emphasized. 5

Study design: Practice guideline

Funding: Foundation

Setting: Various (guideline)

Reviewer

Allen F. Shaughnessy, PharmD, MMedEd
Professor of Family Medicine
Tufts University
Boston, MA


Discuss this POEM


Comments

ARUP KUMAR DHARA

Assessment

Very good

Howard David Koseff

Big Pharma

Does anyone else smell semaglutide lurking or is it just me?

Anonymous

ADA/EASD guidelines

As per the reviewer

Valter Feyles

relevant to day-to-day practice

pointing out the relevant operational aspects in practice

Anonymous

Glycemic control in Type 2 Diabetics

Glad to see strict glycemic control is not the goal in modern management of Type 2 diabetes.

Anonymous

New Diabetes guidelines

SGLT2 and GLP1 are blockbusters but extremely expensive compared to insulin and OS. Good to see they kept metformin!